CAMBRIDGE, Mass.--(BUSINESS WIRE)--Universal Diagnostics (Universal DX), a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced the results ...
Financial support for this work was provided by the UK Biotechnology and Biological Sciences Research Council (BBSRC) Grant Number BB/1013245/1. The author has no other relevant affiliations or ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, demonstrating high sensitivity for both malignant and advanced precancerous lesions ...
Predictive cancer diagnostics company Rhythm Biosciences has achieved a major milestone with the peer-reviewed validation of ...
Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity Findings underscore strength of Natera’s technology for early ...
Saliva-based serology assays that measure antibodies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antigens are important coronavirus disease 2019 (COVID-19) markers. Serology ...
WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and specificity endpoints, according to results from the PREEMPT CRC study. Using ...
Women living with and without HIV, age 30-65 years, were recruited in South Africa. Self-collected vaginal samples and clinician-collected cervical samples were tested with Xpert HPV, an assay that ...
Conclusions Symptoms, the SAC and the m-BESS have poor test-retest reliability. Symptoms have reasonable sensitivity and specificity for concussion but are subjective. The 3-word SAC and m-BESS are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results